As per Intent Market Research, the Egg Freezing and Embryo Banking Market was valued at USD 3.2 Billion in 2024-e and will surpass USD 6.6 Billion by 2030; growing at a CAGR of 12.6% during 2025 - 2030.
The egg freezing and embryo banking market is experiencing significant growth due to advancements in assisted reproductive technology (ART) and an increasing demand for fertility preservation solutions. With the growing trend of delayed childbirth and an increasing number of individuals seeking to preserve their fertility for future family planning, egg freezing and embryo banking have become vital services. These technologies provide women with the option to freeze their eggs or embryos, offering them flexibility in pursuing pregnancy later in life or in cases of infertility.
Moreover, the market is bolstered by the rise in awareness surrounding ART procedures and fertility preservation, making egg freezing and embryo banking more accessible. Research institutes are further enhancing the capabilities of these technologies, improving success rates, and expanding their applicability for medical and non-medical reasons, such as preserving fertility before cancer treatments or for oocyte donation purposes.
Egg Freezing is Dominating the Market driven by its Broad Adoption In Fertility Preservation and Assisted Reproductive Technologies
Egg freezing is the largest segment in the egg freezing and embryo banking market, driven by its broad adoption in fertility preservation and assisted reproductive technologies. As women delay childbearing for various personal, professional, or medical reasons, egg freezing has gained popularity as a way to preserve fertility for later use. The procedure allows women to store their eggs at a young age, giving them the option to use their own eggs for IVF treatments later in life when they may face challenges with fertility due to age or other factors.
The demand for egg freezing is further supported by the increasing number of fertility clinics and medical centers offering these services, along with the growing trend of social egg freezing. Technological advancements have also improved the egg freezing process, enhancing the survival rate of frozen eggs and making it a viable option for women globally. As societal and medical factors continue to influence the timing of childbearing, the egg freezing segment is expected to remain dominant in the market.
Fertility Preservation: Fastest-Growing Application in the Market
Fertility preservation is the fastest-growing application in the egg freezing and embryo banking market, driven by a variety of factors, including cancer treatments, medical conditions, and lifestyle choices. Individuals undergoing treatments such as chemotherapy or radiation, which can affect fertility, increasingly turn to egg and embryo freezing as a means to preserve their fertility before starting treatment. This trend is further supported by the rise in awareness of fertility preservation options and the expanding availability of these services at fertility clinics.
In addition to its medical applications, fertility preservation is gaining traction among individuals who wish to delay childbearing due to personal or career reasons. This growing demand for fertility preservation has contributed to the rapid expansion of this application, making it a key driver of the market's growth. As more people become aware of their fertility preservation options, the demand for egg freezing and embryo banking services is expected to continue rising.
North America is the Leading the Global Market
North America is the leading region in the egg freezing and embryo banking market, driven by a well-established healthcare infrastructure, a high number of fertility clinics, and an increasing acceptance of ART procedures. The region has seen a growing number of women opting for egg freezing as part of their fertility preservation strategy, contributing to the dominance of this market. In addition, the United States is home to several key players in the reproductive healthcare sector, offering advanced technologies and treatments in fertility preservation and embryo banking.
The increasing focus on fertility preservation, especially in light of delayed childbearing trends, is expected to further fuel market growth in North America. Moreover, the supportive regulatory environment and high disposable income in this region have made fertility preservation procedures more accessible, attracting individuals seeking these services. North America is expected to maintain its position as the leading market, with continued advancements in ART technologies and fertility preservation options.
Competitive Landscape and Key Players
The egg freezing and embryo banking market is highly competitive, with several prominent players offering innovative services and technologies in the field of fertility preservation. Key players such as Irvine Scientific, Thermo Fisher Scientific, CooperSurgical, and Fertility Associates are at the forefront of this market, providing a wide range of fertility preservation solutions, including egg and embryo freezing services.
These companies are focusing on expanding their service offerings, improving success rates, and leveraging cutting-edge technologies to cater to the growing demand for fertility preservation. Partnerships, collaborations, and advancements in research are common strategies employed by leading players to strengthen their position in the market. With an increasing number of fertility clinics, hospitals, and research institutes offering ART services, the competitive landscape will continue to evolve, with innovation and customer satisfaction driving market growth.
Recent Developments:
- CryoBank International expanded its egg freezing services and partnered with fertility clinics across North America to offer affordable options.
- Irvine Scientific launched a new product aimed at improving embryo freezing techniques, increasing success rates in IVF treatments.
- Thermo Fisher Scientific Inc. announced the development of an advanced cryopreservation system for egg and embryo banking.
- Ferring Pharmaceuticals acquired a fertility clinic chain to increase its presence in the embryo banking and egg freezing market.
- OvaScience, Inc. introduced a new approach to embryo banking, combining genetic testing and cryopreservation for better patient outcomes.
List of Leading Companies:
- CryoBank International, Inc.
- OvaScience, Inc.
- Irvine Scientific
- Merck KGaA
- Ferring Pharmaceuticals
- Thermo Fisher Scientific Inc.
- ReproTech, Ltd.
- Pre-implantation Genetic Diagnosis (PGD)
- New Hope Fertility Center
- London Women’s Clinic
- California Cryobank
- Gynemed GmbH & Co. KG
- Fertility Preservation Network
- CReATe Fertility Centre
- EmbryoScope
Report Scope:
Report Features |
Description |
Market Size (2024-e) |
USD 3.2 Billion |
Forecasted Value (2030) |
USD 6.6 Billion |
CAGR (2025 – 2030) |
12.6% |
Base Year for Estimation |
2024-e |
Historic Year |
2023 |
Forecast Period |
2025 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Global Egg Freezing and Embryo Banking Market by Type (Egg Freezing, Embryo Freezing), by Application (Fertility Preservation, Assisted Reproductive Technology, Oocyte Donation, Stem Cell Research), by End-Use Industry (Fertility Clinics, Hospitals & Medical Centers, Research Institutes) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
CryoBank International, Inc., OvaScience, Inc., Irvine Scientific, Merck KGaA, Ferring Pharmaceuticals, Thermo Fisher Scientific Inc., Pre-implantation Genetic Diagnosis (PGD), New Hope Fertility Center, London Women’s Clinic, California Cryobank, Gynemed GmbH & Co. KG, Fertility Preservation Network, EmbryoScope |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Egg Freezing and Embryo Banking Market, by Type (Market Size & Forecast: USD Million, 2023 – 2030) |
4.1. Egg Freezing |
4.2. Embryo Freezing |
5. Egg Freezing and Embryo Banking Market, by Application (Market Size & Forecast: USD Million, 2023 – 2030) |
5.1. Fertility Preservation |
5.2. Assisted Reproductive Technology (ART) |
5.3. Oocyte Donation |
5.4. Stem Cell Research |
6. Egg Freezing and Embryo Banking Market, by End-Use Industry (Market Size & Forecast: USD Million, 2023 – 2030) |
6.1. Fertility Clinics |
6.2. Hospitals & Medical Centers |
6.3. Research Institutes |
7. Regional Analysis (Market Size & Forecast: USD Million, 2023 – 2030) |
7.1. Regional Overview |
7.2. North America |
7.2.1. Regional Trends & Growth Drivers |
7.2.2. Barriers & Challenges |
7.2.3. Opportunities |
7.2.4. Factor Impact Analysis |
7.2.5. Technology Trends |
7.2.6. North America Egg Freezing and Embryo Banking Market, by Type |
7.2.7. North America Egg Freezing and Embryo Banking Market, by Application |
7.2.8. North America Egg Freezing and Embryo Banking Market, by End-Use Industry |
7.2.9. By Country |
7.2.9.1. US |
7.2.9.1.1. US Egg Freezing and Embryo Banking Market, by Type |
7.2.9.1.2. US Egg Freezing and Embryo Banking Market, by Application |
7.2.9.1.3. US Egg Freezing and Embryo Banking Market, by End-Use Industry |
7.2.9.2. Canada |
7.2.9.3. Mexico |
*Similar segmentation will be provided for each region and country |
7.3. Europe |
7.4. Asia-Pacific |
7.5. Latin America |
7.6. Middle East & Africa |
8. Competitive Landscape |
8.1. Overview of the Key Players |
8.2. Competitive Ecosystem |
8.2.1. Level of Fragmentation |
8.2.2. Market Consolidation |
8.2.3. Product Innovation |
8.3. Company Share Analysis |
8.4. Company Benchmarking Matrix |
8.4.1. Strategic Overview |
8.4.2. Product Innovations |
8.5. Start-up Ecosystem |
8.6. Strategic Competitive Insights/ Customer Imperatives |
8.7. ESG Matrix/ Sustainability Matrix |
8.8. Manufacturing Network |
8.8.1. Locations |
8.8.2. Supply Chain and Logistics |
8.8.3. Product Flexibility/Customization |
8.8.4. Digital Transformation and Connectivity |
8.8.5. Environmental and Regulatory Compliance |
8.9. Technology Readiness Level Matrix |
8.10. Technology Maturity Curve |
8.11. Buying Criteria |
9. Company Profiles |
9.1. Primex EHF |
9.1.1. Company Overview |
9.1.2. Company Financials |
9.1.3. Product/Service Portfolio |
9.1.4. Recent Developments |
9.1.5. IMR Analysis |
*Similar information will be provided for other companies |
9.2. Golden-Shell Pharmaceutical Co. Ltd. |
9.3. ChitoTech Co., Ltd. |
9.4. KitoZyme SA |
9.5. BioPrism |
9.6. Zhejiang New Fuda Chemical Co. Ltd. |
9.7. Fujian Fengzu Biological Technology Co., Ltd. |
9.8. Panvo Organics Pvt. Ltd. |
9.9. Hubei Hengxin Chitosan Co. Ltd. |
9.10. Haixin Chitosan Co., Ltd. |
9.11. Kanglida Food Additive Co., Ltd. |
9.12. Qingdao Luwei Pharmaceutical Co., Ltd. |
9.13. Novamatrix (CP Kelco) |
9.14. NutriPharma Co., Ltd. |
9.15. Vanson Active Ingredients Co., Ltd. |
10. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Egg Freezing and Embryo Banking Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Egg Freezing and Embryo Banking Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary Research
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary Research
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
- Validating findings and assumptions derived from secondary research
- Gathering qualitative and quantitative data on market trends, drivers, and challenges
- Understanding the demand-side dynamics, encompassing end-users, component manufacturers, facility providers, and service providers
- Assessing the supply-side landscape, including technological advancements and recent developments
Market Size Assessment
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Egg Freezing and Embryo Banking Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
- Identification of key industry players and relevant revenues through extensive secondary research
- Determination of the industry's supply chain and market size, in terms of value, through primary and secondary research processes
- Calculation of percentage shares, splits, and breakdowns using secondary sources and verification through primary sources
Data Triangulation
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.
NA